← back to search

Massimiliano Salati

University of Massachusetts Chan Medical School · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Medicine, Oncology, Internal medicine, Colorectal cancer, Chemotherapy, and Immune checkpoint.
h-index
citations
546
works
10
NIH funding
primary concept
email

Recent publications

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
JAMA Oncology 2025cited by 18position: middledoi
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Gut 2023cited by 23position: middledoi
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Journal for ImmunoTherapy of Cancer 2022cited by 117position: middledoi
The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors
European Journal of Cancer 2021cited by 109position: middledoi
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
JHEP Reports 2021cited by 67position: middledoi
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2021cited by 23position: middledoi
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden
The Oncologist 2020cited by 50position: middledoi
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
Gut 2020cited by 42position: middledoi
The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer
Liver International 2019cited by 57position: firstdoi
Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry
Annals of Epidemiology 2015cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Giuseppe Curigliano · Istituti di Ricovero e Cura a Carattere Scientifico3 papers (2020–2021)Elisabetta Fenocchio · Verizon (United States)3 papers (2019–2021) · 3 papers (2019–2021)Sara Lonardi · Istituto Oncologico Veneto3 papers (2020–2021)Francesca Corti · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico3 papers (2020–2021)Federica Morano · European Neuroendocrine Tumor Society3 papers (2020–2021)Filippo Pietrantonio · Genome Institute of Singapore3 papers (2020–2021)Giovanni Fucà · University of Padua3 papers (2020–2021)Margherita Ambrosini · Fondazione IRCCS Istituto Nazionale dei Tumori2 papers (2021–2021)Carmen Belli · European Institute of Oncology2 papers (2020–2021)Filippo de Braud · National Cancer Institute2 papers (2020–2021)Rossana Intini · University of Padua2 papers (2021–2021) · 2 papers (2019–2020)Matteo Fassan · University of Padua2 papers (2020–2021)Michael J. Overman · The University of Texas MD Anderson Cancer Center1 papers (2021–2021)Aakash Tushar Shah · Baylor College of Medicine1 papers (2021–2021)Massimo Di Maïo · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino1 papers (2019–2019)Priya Jayachandran · University of Southern California1 papers (2021–2021)Alessandra Anna Prete · Università Campus Bio-Medico1 papers (2021–2021)Alessandra Raimondi · Fondazione IRCCS Istituto Nazionale dei Tumori1 papers (2020–2020)